Become a Member

Task Forces

Task forces are projects that deal with specific topics that are relevant, controversial or new in the field. All EAACI members can apply for a specific task forces in alignment with the chair and secretary of a specific section or interest group. All task forces are supported by EAACI and have been approved by the Executive Committee. Should you wish to reach out to the particular TF Group, kindly direct your inquiries to: science@eaaci.org

All Task Forces
  • Task Forces
    2024

    Skin Allergy Club (SAC) 2024

    Read more
  • Task Forces
    2024

    Mechanisms and biomarkers involved in Drug Hypersensitivity Reactions

    Read more
  • Task Forces
    2024

    WHO-IUIS Allergen Nomenclature Committee

    Read more
  • Task Forces
    2024

    Zoonotic diseases in our times

    Read more
  • Task Forces
    2024

    The use of omic sciences in asthma and allergy clinical practice

    Read more
  • Task Forces
    2024

    “IgE binding proteins from bacteria, protozoans, helminths and fungi and their impact on precision diagnosis and prevention of allergic diseases”- Acronyme: BACALL

    Read more
  • Task Forces
    2024

    Beyond MAUG 2.0: Molecular Allergology in Practice

    Read more
  • Task Forces
    2024

    Standardization of skin prick testing: sensitization patterns of inhalant allergens in Europe

    Read more
  • Task Forces
    2024

    ROC ENT group Task Force series

    Read more
  • Task Forces
    2024

    Emerging environmental factors influencing insect (venom) allergy

    Read more
  • Task Forces
    2024

    Prevalence and predictive factors for co-morbid CRS and asthma

    Read more
  • Task Forces
    2024

    Development of an easy and automate tool for WG/IG and IS evaluation- “e-VALUATION”

    Read more
  • Task Forces
    2024

    Joint-Task Force Proposal for Clinical Practice Recommendations on Environmental Greenness and Allergic Diseases

    Read more
  • Task Forces
    2024

    Neonatal bathing practices and atopic dermatitis: protecting epithelial barrier from the first day

    Read more
  • Task Forces
    2024

    Task force on Hypersensitivity to Excipients In Drugs

    Read more
  • Task Forces
    2024

    AWARE – Expanding Awareness in Adults with Rare Errors of Immunity

    Read more
  • Task Forces
    2024

    Immunology of post-infectious diseases

    Read more
  • Task Forces
    2024

    The new nomenclature for allergic diseases and asthma

    Read more
  • Task Forces
    2024

    Therapeutic education for patients with asthma

    Read more
  • Task Forces
    2024

    European Academy of Allergy and Clinical Immunology Task Force on HES: towards a personalized patient-centered care

    Read more
  • Task Forces
    2024

    Phenotypes and endotypes of pediatric asthma

    Read more
  • Task Forces
    2024

    Assessment of the burden of plastic exposure in European countries

    Read more
  • Task Forces
    2024

    Recommendations for prevention and management of adverse reactions to biologics

    Read more
  • Task Forces
    2024

    Minimal Clinically Important Difference (MCID) of clinical endpoints in AIT

    Read more
  • Task Forces
    2024

    INTERAID (International travel electronic support in respiratory, allergy, immunology and dermatology): Digitally-enabled, person-centred care to support travelling patients with allergic rhinitis, asthma, urticaria (and COPD)

    Read more
  • Task Forces
    2024

    Harmonising betalactam cross reactivity and safe alternatives

    Read more
  • Task Forces
    2024

    Update in the classification of hypersensitivity reactions to non-steroidal anti-inflammatory drugs

    Read more
  • Task Forces
    2024

    Updated guidelines on the risk assessment and methodology of skin tests for the investigation of drug allergy

    Read more
  • Task Forces
    2024

    European network for the PHenotyping of OCcupational ASthma – E-PHOCAS-Phase II 2024

    Read more
  • Task Forces
    2024

    Clinical diagnosis and management of severe cutaneous adverse drug reactions (SCARs) in children: an ENDA/EAACI pediatric task force report

    Read more
  • Task Forces
    2024

    Sport activities and exercise options for children with allergies

    Read more
  • Task Forces
    2023

    Roadmap for the management of EoE

    Read more
  • Task Forces
    2023

    Novel mechanisms in allergic inflammation

    Read more
  • Task Forces
    2023

    AllergoOncology in the Era of Personalized, Stratified and Precision medicine (STRATALLON)

    Read more
  • Task Forces
    2023

    Macrophage role in Allergy and Cancer: Novel therapeutic opportunities

    Read more
  • Task Forces
    2023

    Human Skin Microbiota

    Read more
  • Task Forces
    2023

    Severe atopic dermatitis associated with hypogammaglobulinemia

    Read more
  • Task Forces
    2023

    Anti-inflammatory effect of anti-muscarinic antagonists

    Read more
  • Task Forces
    2023

    Managing the upcoming increase in asthma prevalence cause by the war in Ukraine

    Read more
  • Task Forces
    2023

    Under- and over-diagnosis of asthma

    Read more
  • Task Forces
    2023

    Occupational Mite Allergy and Asthma (OMAA)

    Read more
  • Task Forces
    2023

    Health economics of allergen immunotherapy

    Read more
  • Task Forces
    2023

    Sting Challenge Test

    Read more
  • Task Forces
    2023

    Aeroallergen immunotherapy before five years of age and elderly

    Read more
  • Task Forces
    2023

    Nocebo effect of allergen immunotherapy

    Read more
  • Task Forces
    2023

    Allergen immunotherapy and co-evaluation of COVID-19 vaccines

    Read more
  • Task Forces
    2023

    Allergen Immunotherapy and Biologicals

    Read more
  • Task Forces
    2023

    Mast cell activation test

    Read more
  • Task Forces
    2023

    Immediate and delayed hypersensitivity to biologicals in children – a practical approach

    Read more
  • Task Forces
    2023

    EUropean RegIstry of food Protein-InduceD Enterocolitis Syndrome (EURIPIDES)

    Read more
  • Task Forces
    2023

    Eosinophilic esophagitis and allergen immunotherapy

    Read more
  • Task Forces
    2023

    EAACI primary care paediatricians allergy educational needs Task Force

    Read more
  • Task Forces
    2023

    How EAACI recommendations on ocular allergy diagnosis and treatment are applied in real life clinical practice: an international multidisciplinary survey

    Read more
  • Task Forces
    2023

    Skin Allergy Club (SAC) 2023

    Read more
  • Task Forces
    2023

    Prevalence and predictive factors for co-morbid CRS and asthma

    Read more
  • Task Forces
    2023

    Understanding accidental food exposure risk in children and young people with food allergies in Europe

    Read more
  • Task Forces
    2023

    Joint Task Force on the role of residential greenness exposure in the multifactorial pathway towards allergy and asthma (EAACI statement)

    Read more
  • Task Forces
    2023

    Human Gut Microbiome

    Read more
  • Task Forces
    2023

    Exercise and physical activity for asthma management: an EAACI task force position paper

    Read more
  • Task Forces
    2023

    Defining “Immunonutrition”

    Read more
  • Task Forces
    2023

    Weaning practices: a survey on the pediatrician’s approaches

    Read more
  • Task Forces
    2023

    Updated treatment of N-ERD: Aspirin desensitization versus Biologics: Evidence-based recommendations: To whom, When, How

    Read more
  • Task Forces
    2023

    Use of biologics in the management of rare eosinophilic diseases

    Read more
  • Task Forces
    2023

    VAccine Responses in BIOlogical therapies (VARBIO)

    Read more
  • Task Forces
    2023

    AtoPID

    Read more
  • Task Forces
    2023

    Conscious and rational use of antibiotics in allergic diseases

    Read more
  • Task Forces
    2023

    EAACI position paper on the diagnosis and therapeutic management of allergic bronchopulmonary aspergillosis (ABPA)

    Read more
  • Task Forces
    2023

    Immunometabolism in allergy and asthma – AllerIMMET

    Read more
  • Task Forces
    2023

    Public outreach for immunological mechanisms in allergies and asthma

    Read more
  • Task Forces
    2023

    Emerging, altering and underestimated aeroallergens on a changing Planet: Impacts on allergic diseases

    Read more
  • Task Forces
    2023

    Drug-induced periocular and ocular surface disorders

    Read more
  • Task Forces
    2023

    Principles for targeting eicosanoids in the treatment of asthma and allergic diseases

    Read more
  • Task Forces
    2023

    Endotyping in CRS

    Read more
  • Task Forces
    2023

    Urticaria and anaphylaxis in endurance and ultra-endurance athletes: a proposal for pre-race risk assessment

    Read more
  • Task Forces
    2023

    Alpine Altitude Climate Treatment (previously High Altitude Climate Treatment HACT)

    Read more
  • Task Forces
    2023

    Diagnosis of fluoroquinolone hypersensivity

    Read more
  • Task Forces
    2023

    Better defining the roles of non-allergy specialists healthcare professionals in the management of allergic disorders

    Read more
  • Task Forces
    2023

    Management of adverse reactions to anticoagulants

    Read more
  • Task Forces
    2023

    Urticarial vasculitis

    Read more
  • Task Forces
    2023

    Validation of Clinical endpoints in AIT (with MASK technology)

    Read more
  • Task Forces
    2023

    Allergic diseases in adolescents and young people, towards better patient centred care

    Read more
  • Task Forces
    2023

    Interdisciplinary TF group “Allergen Challenge Chambers (AEC): state of the arts and needs for the future” – Phase III

    Read more
  • Task Forces
    2023

    Food Allergen Thresholds

    Read more
  • Task Forces
    2023

    Interdisciplinary TF group “Definition of clinical-relevant thresholds of allergen-exposure for analysis of outcomes in AIT”_ Phase III

    Read more
  • Task Forces
    2023

    Joint-TF of CVA and One Health “Intersection of Comparative Allergology and One Health”

    Read more
  • Task Forces
    2023

    Omic technologies in allergy research

    Read more
  • Task Forces
    2023

    Feeding difficulties in children with food allergies

    Read more
  • Task Forces
    2023

    Micronutrients

    Read more
  • Task Forces
    2023

    Harmonization of clinical outcomes of efficacy in Food-AIT trials

    Read more
  • Task Forces
    2023

    Systematic review on the dietary interventions in children after acute respiratory or skin infections

    Read more
  • Task Forces
    2023

    E-learning material about AllergoOncology

    Read more
  • Task Forces
    2023

    Ultraprocessed foods and allergy outcomes: Stopping a global epidemic

    Read more
  • Task Forces
    2023

    Granulocytes (mast cells, basophils, neutrophils eosinophils): understanding their roles in allergy and tumour immunity

    Read more
  • Task Forces
    0202

    Immunopharmacology: non-biological therapeutic approaches in allergy and clinical immunology

    Read more